The beneficial therapeutic effects of RASi on DKD, while independent of its antihypertensive properties (Nobakht et al. 2011), depend on its vasodilatory effect in efferent arterioles (Roscioni et al. 2014; Naaman and Bakris 2023). Here, MMP19 is linked to diabetic kidney disease.